Amanta Healthcare Intrinsic Value
AMANTA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹110.00 | ₹88.00 - ₹132.00 | +10.6% | EPS: ₹5.00, Sector P/E: 22x |
| Book Value Method | asset | ₹66.21 | ₹59.59 - ₹72.83 | -33.5% | Book Value/Share: ₹33.10, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹196.55 | ₹176.90 - ₹216.21 | +97.5% | Revenue/Share: ₹98.28, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹199.00 | ₹179.10 - ₹218.90 | +100.0% | EBITDA: ₹63.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹189.25 | ₹151.40 - ₹227.10 | +90.2% | CF Growth: 11.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹32.00 | ₹28.80 - ₹35.20 | -67.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹77.20 | ₹69.48 - ₹84.92 | -22.4% | Revenue Growth: 5.9%, Adj P/E: 15.4x |
| ROE Based Valuation | profitability | ₹72.41 | ₹65.17 - ₹79.65 | -27.2% | ROE: 15.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹61.03 | ₹54.93 - ₹67.13 | -38.7% | EPS: ₹5.00, BVPS: ₹33.10 |
Want to compare with current market value? Check AMANTA share price latest .
Valuation Comparison Chart
AMANTA Intrinsic Value Analysis
What is the intrinsic value of AMANTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Amanta Healthcare (AMANTA) is ₹77.20 (median value). With the current market price of ₹99.50, this represents a -22.4% variance from our estimated fair value.
The valuation range spans from ₹32.00 to ₹199.00, indicating ₹32.00 - ₹199.00.
Is AMANTA undervalued or overvalued?
Based on our multi-method analysis, Amanta Healthcare (AMANTA) appears to be trading above calculated value by approximately 22.4%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.81 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 15.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.75x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Amanta Healthcare
Additional stock information and data for AMANTA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹47 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹58 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹40 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹62 Cr | ₹59 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹31 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |